HIV/AIDS epidemiology, pathogenesis, prevention, and treatment

被引:392
作者
Simon, Viviana
Ho, David D.
Karim, Quarraisha Abdool
机构
[1] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10021 USA
[2] Univ Kwazulu Natal, Ctr AIDS Programme Res S Africa, Durban, South Africa
[3] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA
基金
美国国家卫生研究院;
关键词
D O I
10.1016/S0140-6736(06)69157-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The HIV-1 pandemic is a complex mix of diverse epidemics within and between countries and regions of the world, and is undoubtedly the defining public-health crisis of our time. Research has deepened our understanding of how the virus replicates, manipulates, and hides in an infected person. Although our understanding of pathogenesis and transmission dynamics has become more nuanced and prevention options have expanded, a cure or protective vaccine remains elusive. Antiretroviral treatment has transformed AIDS from an inevitably fatal condition to a chronic, manageable disease in some settings. This transformation has yet to be realised in those parts of the world that continue to bear a disproportionate burden of new HIV-1 infections and are most affected by increasing morbidity and mortality. This Seminar provides an update on epidemiology, pathogenesis, treatment, and prevention interventions pertinent to HIV-1.
引用
收藏
页码:489 / 504
页数:16
相关论文
共 207 条
[1]   Interruption of antiretroviral therapy to augment immune control of chronic HIV-1 infection: Risk without reward [J].
Abbas, UL ;
Mellors, JW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (21) :13377-13378
[2]  
[Anonymous], 13 C RETR OPP INF DE
[3]   Advances in multilevel approaches to understanding the epidemiology and prevention of sexually transmitted infections and HIV: An overview [J].
Aral, SO ;
Padian, NS ;
Holmes, KK .
JOURNAL OF INFECTIOUS DISEASES, 2005, 191 :S1-S6
[4]   Measuring outcomes of behavioural interventions for STD/HIV prevention [J].
Aral, SO ;
Peterman, TA .
INTERNATIONAL JOURNAL OF STD & AIDS, 1996, 7 :30-38
[5]   Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: The ANRS 1265 trial [J].
Auvert, B ;
Taljaard, D ;
Lagarde, E ;
Sobngwi-Tambekou, J ;
Sitta, M ;
Puren, A .
PLOS MEDICINE, 2005, 2 (11) :1112-1122
[6]   Effectiveness and cost effectiveness of early and late prevention of HIV/AIDS progression with antiretrovirals or antibiotics in Southern African adults [J].
Bachmann, MO .
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2006, 18 (02) :109-120
[7]   Initiating highly active antiretroviral therapy in sub-Saharan Africa: an assessment of the revised World Health Organization scaling-up guidelines [J].
Badri, M ;
Bekker, LG ;
Orrell, C ;
Pitt, J ;
Cilliers, F ;
Wood, R .
AIDS, 2004, 18 (08) :1159-1168
[8]  
Bailey Robert C, 2005, AIDS Read, V15, P136
[9]   CXCR4-Tropic HIV-1 envelope glycoprotein functions as a viral chemokine in unstimulated primary CD4+ T lymphocytes [J].
Balabanian, K ;
Harriague, J ;
Décrion, C ;
Lagane, B ;
Shorte, S ;
Baleux, F ;
Virelizier, JL ;
Arenzana-Seisdedos, F ;
Chakrabarti, LA .
JOURNAL OF IMMUNOLOGY, 2004, 173 (12) :7150-7160
[10]   HIV as the cause of AIDS [J].
BarreSinoussi, F .
LANCET, 1996, 348 (9019) :31-35